The Portfolio · BriefLatest →

FERMENTA · Fermenta Biotech Limited · BSE · Filed 16 Jun · 1 min read

Fermenta Biotech applies to NSE for direct listing of its equity shares

The company told BSE it has filed an application with the National Stock Exchange seeking approval to list and trade its equity shares via the direct listing route.

What was filed

Fermenta Biotech Limited informed BSE on June 16, 2026 that, on the same date, it had made an application to the National Stock Exchange of India Limited (NSE) seeking approval for the listing and trading of the company's equity shares on NSE's platform. The filing specifies that this is being pursued through a direct listing route.

The company noted that this step is in continuation of an earlier intimation it had filed dated May 26, 2026.

What it means for a holder

The filing records an administrative milestone rather than a completed event: an application has been submitted to NSE, and approval has not yet been confirmed in this disclosure. The company's shares already trade on BSE under code 506414. The stated objective of the application is to add NSE as a listing and trading venue.

No financial terms, timelines, or conditions are disclosed in the filing. The intimation is limited to the fact that the application was made.

For a holder, the disclosure signals that the company is pursuing an additional exchange listing on NSE alongside its existing BSE listing; the outcome depends on NSE's approval, which this filing does not confirm.